Posts

19 min read – Over the last year, I spent a lot of time thinking about what the field of AI could learn from the pharmaceutical industry. As a physician who has worked in clinical trials, I am intimately familiar with the processes there and learned to deeply appreciate them over time. I also spent…

→ read

2 min read – My learning resource for students of the human cell available now for free in English, Spanish, Chinese and German.

→ read

7 min read – Even within hospitals and despite being health care experts themselves non-emergency doctors and nurses hand off patients who need CPR quickly to specialized teams to ensure best possible care. Time and expertise matter. We need Pharmaceutical Response and Preparedness Special Forces.

→ read

4 min read – Core culture principles and activities that we believe enabled the team to achieve exceptional results.

→ read

11 min read – One begins to wonder – why does drug development necessitate all this rigour, time, and money? Understanding drug development’s history might offer context.

→ read

15 min read – In this article we explore the phases of drug development and how stakeholders live up to Good Practices (GxP) which ensure pharmaceutical products’ quality, safety, and efficacy.

→ read

13 min read – This is the first piece of our six-part series that aims to provide a foundational understanding for those interested in drug development, beginning with the field’s stakeholders.

→ read

< 1 min read – A Comprehensive but Concise Introduction to the Drug Development Landscape and its Regulation. If you want to get up to speed in ~1h on how pharma works, this series is for you.

→ read

4 min read – Picking the right charity can be overwhelming. In this post I argue that collaborating with others to determine a donation portfolio across different charity domains is an underrated activity.

→ read